Journal of the American Chemical Society · 2006 · 146 citations · 7 references
Natural SciencesBiochemistryChemistryInorganic ChemistryMetabolismRedox BiochemistryIron Chelation TherapyIron HomeostasisIron MetabolismReactive Oxygen SpeciesRedox CatalysisRedox ChemistryFenton ReactionHydroxyl Radical GenerationIron BiochemistryIron ComplexationIron Redox ChemistryRate-determining StepRedox-active LigandsRedox-active Metals
The synthesis and structural characterization of a new pro-chelating agent, isonicotinic acid [2-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzylidene]-hydrazide (BSIH), are presented. BSIH only weakly interacts with iron unless hydrogen peroxide (H2O2) is present to remove the boronic ester protecting group to reveal a phenol that is a key metal-binding group of tridentate salicylaldehyde isonicotinoyl hydrazone (SIH). BSIH prevents deoxyribose degradation caused by hydroxyl radicals that are generated from H2O2 and redox-active iron by sequestering Fe3+ and preventing iron-promoted hydroxyl radical formation. The rate-determining step for iron sequestration is conversion of BSIH to SIH, followed by rapid Fe3+ complexation. The pro-chelate approach of BSIH represents a promising strategy for chelating a specific pool of detrimental metal ions without disturbing healthy metal ion distribution.
7
Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo
Deepinder Kaur, Ferda Yantiri, Subramanian Rajagopalan et al. · Neuron · 2003 · 619 citations · Full text
Tomáš Šimůnek, Christa Boer, R. Arthur Bouwman et al. · Journal of Molecular and Cellular Cardiology · 2005 · 92 citations · Full text